Literature DB >> 19764010

Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol.

Mohammad Tezval1, Stephan Sehmisch, Dana Seidlová-Wuttke, Thomas Rack, Leila Kolios, Wolfgang Wuttke, Klaus Michael Stuermer, Ewa Klara Stuermer.   

Abstract

The isoflavonoids found in soy have attracted great interest as dietary phytoestrogens that might be effective for postmenopausal hormone replacement therapy. Special attention has been devoted to the hormonal effects of various isoflavonoids, like genistein (GEN) and daidzein's (DAID) potent metabolite, equol (EQ). Here we aimed to investigate the short-term effects of genistein and equol on the proximal femur of ovariectomized (OVX) rats. Forty-eight, 3-month-old female Sprague-Dawley rats were ovarectomized; after eight weeks the bilateral osteotomy and osteosynthesis (OS) of their tibiae was performed and the rats were randomly divided into the following four groups: OVX control group (C), treated with estradiol-17beta (E2) -benzoate (E; daily intake 0.086 mg/d per animal), genistein (GEN; daily intake 12.7 mg/d per animal) and equol (EQ; daily intake 4.65 mg/d per animal). At 5 weeks postoperatively (OS), the breaking test was performed on the trochanteric region of femur. Additionally, histomorphometric assessment, and trabecular and cortical bone microstructure analyses were performed. The relative gain of body weight (BW) in the EQ (24 %) group was significantly (p < 0.05) lower than in the C (33 %) and GEN (30 %) groups. After treatment for 5 weeks, the maximal load (F(max)) and yield load (yL) were higher (p < 0.05 for the weight-adapted results) in the E (188.4 N resp. 113.1 N) and EQ (177.3 N resp. 112 N) groups as compared to C (162.8 N resp. 109.1 N) and GEN (165.7 N resp. 108.8 N). In the histomorphometric tests the E- (trabecular area (Tb.Ar) = 74.93 %, trabecular nodes/mm(2) (N.Nd/mm(2)) = 48.65) and EQ-treated (Tb.Ar = 63.13 %, N.Nd/mm(2) = 43.72) animals showed significant improvement with regard to Tb.Ar and trabecular connectivity (N.Nd./mm(2)) in comparison to C (Tb.Ar = 46.84, N.Nd/mm(2) = 31.86) and GEN (Tb.Ar = 48.22 %, N.Nd/mm(2) = 34.15). There were no differences in relative cortical width (Ct.Wi) among the four groups. The treatment with EQ resulted in improved biomechanical and histomorphometric properties as compared to the treatment with GEN. Thus, of the studied substances, EQ seems to be a possible alternative to hormone replacement therapy, but further studies are needed. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764010     DOI: 10.1055/s-0029-1186136

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

1.  Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss.

Authors:  Connie M Weaver; Leecole L Legette
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 2.  Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.

Authors:  Xi Zheng; Sun-Kyeong Lee; Ock K Chun
Journal:  J Med Food       Date:  2015-12-15       Impact factor: 2.786

3.  The effects of parathyroid hormone applied at different regimes on the trochanteric region of the femur in ovariectomized rat model of osteoporosis.

Authors:  M Tezval; A Banhardt; S Sehmisch; L Kolios; U Schmelz; K M Stuermer; E K Stuermer
Journal:  J Osteoporos       Date:  2011-04-13

4.  Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized rats.

Authors:  LeeCole L Legette; Jeevan Prasain; Jennifer King; Ali Arabshahi; Stephen Barnes; Connie M Weaver
Journal:  J Agric Food Chem       Date:  2014-01-29       Impact factor: 5.279

5.  Effects of Extracts from Trifolium medium L. and Trifolium pratense L. on Development of Estrogen Deficiency-Induced Osteoporosis in Rats.

Authors:  Urszula Cegieła; Joanna Folwarczna; Maria Pytlik; Grażyna Zgórka
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-29       Impact factor: 2.629

Review 6.  Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis.

Authors:  Xin Xu; Xiaoyue Jia; Longyi Mo; Chengcheng Liu; Liwei Zheng; Quan Yuan; Xuedong Zhou
Journal:  Bone Res       Date:  2017-10-04       Impact factor: 13.567

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.